What You Should Know:
- The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance.
- The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.
- Digital diabetes solutions have disrupted the
Read More
LifeScan
Express Scripts Launches First Digital Health Formulary for Apps & Devices
- Express Scripts launches its first digital health formulary that will allow employers and health plans to effectively manage a fast-growing segment of healthcare while improving access for patients.- Starting in January 2020, Express Scripts Digital Health Formulary will initially include 15 solutions for remote monitoring services and digital therapeutics that aid in the management of eight of the country's most common chronic conditions: diabetes, prediabetes, hypertension, asthma, pulmonary
Read More
WellDoc, LifeScan Integrate to Create Type 2 Diabetes Management Platform
WellDoc has entered a commercial partnership agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company (JJDCC), to deliver a best-in-class digital health solution for individuals living with Type 2 diabetes. The combined offering will seek to create a comprehensive, data-driven and payer-reimbursed program for Type 2 diabetes management.WellDoc’s BlueStar® diabetes management platform and mobile app is the first digital therapeutic approved by the U.S. Food and Drug
Read More
